Disc Medicine, INC Schedule 13D activist filings

Atlas Venture funds have reduced their beneficial ownership in Disc Medicine, Inc. to below 5% primarily due to dilution from new share issuances, alongside recent stock sales.

AI DMI LLC, an entity controlled by Len Blavatnik, completed a secondary offering of Disc Medicine, Inc. common stock, generating $58.7 million in net proceeds.

Atlas Venture entities have significantly reduced their beneficial ownership in Disc Medicine, Inc. through a series of common stock sales.

OrbiMed Advisors and its affiliated entities have filed an Amendment No. 5 to their Schedule 13D, indicating they have ceased to be beneficial owners of more than 5% of Disc Medicine, Inc.'s common stock following recent share dispositions.

Access Industries and its affiliated entities have filed an Amendment No. 5 to their Schedule 13D, confirming their continued beneficial ownership of 10.8% of Disc Medicine, Inc.'s common stock.